Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Elanco Animal Health Incorporated (ELAN)

26.27   0.73 (2.86%) 11-19 16:03
Open: 25.71 Pre. Close: 25.54
High: 26.64 Low: 25.48
Volume: 6,123,993 Market Cap: 9799M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 26.663 - 26.851 26.851 - 26.997
Low: 25.146 - 25.341 25.341 - 25.493
Close: 26.032 - 26.338 26.338 - 26.576

Technical analysis

as of: 2019-11-19 4:25:52 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 31.33     One year: 32.47
Support: Support1: 25.25    Support2: 21.01
Resistance: Resistance1: 26.83    Resistance2: 27.80
Pivot: 26.61
Moving Average: MA(5): 25.85     MA(20): 26.64
MA(100): 28.78     MA(250): 30.56
MACD: MACD(12,26): -0.27     Signal(9): -0.18
Stochastic oscillator: %K(14,3): 28.63     %D(3): 18.95
RSI: RSI(14): 47.32
52-week: High: 35.46  Low: 25.25  Change(%): -20.6
Average Vol(K): 3-Month: 388574  10-Days: 578107

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ELAN has closed above bottom band by 37.9%. Bollinger Bands are 17.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-11-15
Elanco Animal Health (NYSE:ELAN) Sets New 1-Year Low at $25.43
Elanco Animal Health (NYSE:ELAN)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $25.43 and last traded at $25.70, with a volume of 97899 shares traded. The stock had previously closed at $26.00. ELAN has been the subject of several recent research reports. Cleveland Research […]

2019-11-07
Morgan Stanley Upgrades Elanco Animal Health On Valuation
While Elanco Animal Health Inc’s (NYSE: ELAN ) current valuation reflects the ongoing investor concerns, the focus is now likely to shift to the positives related to the Bayer transaction, prospects of margin expansion and long-term pipeline potential over 20202, according to Morgan Stanley. The Analyst Morgan Stanley’s David Risinger upgraded Elanco Animal Health from Equal-Weight to Overweight while reducing the price target from $34 to $32. The Thesis Elanco Animal Health’s shares have declined by 15% year to date, significantly underperforming the broader market and key competitor Zoetis Inc (NYSE: ZTS ), Risinger said in the note. Investors currently appear skeptical about the decision … Full story available on Benzinga.com

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange: 
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 373.00
Shares Float (M) 372.65
% Held by Insiders 0.19
% Held by Institutions 35.45
Shares Short (K) 14850
Shares Short P. Month (K)

Stock Financials

EPS 0.250
Book Value (p.s.) 14.710
PEG Ratio 2.34
Profit Margin 3.04
Operating Margin 13.84
Return on Assets (ttm) 3.0
Return on Equity (ttm) 1.8
Qtrly Rev. Growth 1.3
Gross Profit (p.s.) 4.102
Sales Per Share
EBITDA (p.s.) 1.961
Qtrly Earnings Growth -83.40
Operating Cash Flow (M) 237.30
Levered Free Cash Flow (M) 267.10

Stock Valuations

P/E 105.16
P/E Growth Ratio 0.03
P/BV 1.79
P/S 3.13
P/CF 41.32

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.